Stephen N. Davis

17.7k total citations · 5 hit papers
202 papers, 13.2k citations indexed

About

Stephen N. Davis is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Stephen N. Davis has authored 202 papers receiving a total of 13.2k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Endocrinology, Diabetes and Metabolism, 77 papers in Surgery and 42 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Stephen N. Davis's work include Diabetes Management and Research (133 papers), Pancreatic function and diabetes (70 papers) and Diabetes Treatment and Management (64 papers). Stephen N. Davis is often cited by papers focused on Diabetes Management and Research (133 papers), Pancreatic function and diabetes (70 papers) and Diabetes Treatment and Management (64 papers). Stephen N. Davis collaborates with scholars based in United States, United Kingdom and Australia. Stephen N. Davis's co-authors include Philip E. Cryer, Harry Shamoon, Donna B. Tate, William C. Duckworth, Domenic J. Reda, Rodney A. Hayward, Peter D. Reaven, Maka S. Hedrington, Nicholas Emanuele and Grant D. Huang and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Circulation Research.

In The Last Decade

Stephen N. Davis

197 papers receiving 12.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

2008 3.4k citations Stephen N. Davis et al. profile →
Hypoglycemia in Diabetes

2003 851 citations Stephen N. Davis et al. profile →
Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease

2003 810 citations Stephen N. Davis et al. profile →
Hypoglycemia in diabetes.

2003 756 citations Stephen N. Davis et al. PubMed profile →
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

2010 651 citations John B. Buse, Stephen N. Davis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen N. Davis United States	52	9.0k	3.8k	2.4k	2.3k	2.2k	202	13.2k
Geremia B. Bolli Italy	61	8.9k 1.0×	4.9k 1.3×	3.0k 1.2×	1.6k 0.7×	1.9k 0.8×	237	11.5k
Samuel Dagogo‐Jack United States	47	7.2k 0.8×	2.6k 0.7×	1.3k 0.5×	2.0k 0.8×	2.4k 1.1×	201	11.2k
Ramón Gomis Spain	47	8.6k 0.9×	3.1k 0.8×	1.4k 0.6×	1.9k 0.8×	3.8k 1.7×	174	14.8k
Ryuzo Kawamori Japan	62	6.2k 0.7×	3.8k 1.0×	2.3k 0.9×	2.6k 1.1×	4.3k 1.9×	447	15.3k
Franco Folli Italy	60	3.6k 0.4×	4.2k 1.1×	2.7k 1.1×	2.7k 1.2×	3.9k 1.8×	198	12.9k
George Grunberger United States	52	6.9k 0.8×	3.5k 0.9×	1.7k 0.7×	1.4k 0.6×	3.2k 1.5×	161	10.9k
Andrea Mari Italy	68	9.3k 1.0×	6.7k 1.8×	2.0k 0.8×	4.0k 1.7×	4.6k 2.1×	287	15.1k
Naoko Tajima Japan	46	5.4k 0.6×	1.9k 0.5×	1.5k 0.6×	1.9k 0.8×	2.1k 0.9×	235	11.0k
Abbas E. Kitabchi United States	64	9.0k 1.0×	3.0k 0.8×	4.8k 2.0×	3.2k 1.4×	2.9k 1.3×	237	15.6k
Hirotaka Watada Japan	63	6.4k 0.7×	5.2k 1.4×	2.8k 1.2×	2.2k 0.9×	4.8k 2.1×	502	14.8k

Countries citing papers authored by Stephen N. Davis

Since Specialization

Citations

This map shows the geographic impact of Stephen N. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen N. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen N. Davis more than expected).

Fields of papers citing papers by Stephen N. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen N. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen N. Davis. The network helps show where Stephen N. Davis may publish in the future.

Co-authorship network of co-authors of Stephen N. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen N. Davis. A scholar is included among the top collaborators of Stephen N. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen N. Davis. Stephen N. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Munir, Kashif M., et al.. (2025). What is our current understanding of insulin-derived amyloidosis?. Expert Opinion on Drug Safety. 1–4.

Davis, Stephen N., et al.. (2025). Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure. Nephrology Dialysis Transplantation. 41(1). 31–41. 1 indexed citations

Davis, Stephen N., et al.. (2021). Sodium–glucose cotransporter 2 inhibitors for the management of type 2 diabetes. Expert Opinion on Pharmacotherapy. 22(16). 2181–2198. 2 indexed citations

Joy, Nino G., et al.. (2016). Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes. Metabolism. 65(12). 1695–1705. 16 indexed citations

Malek, Rana & Stephen N. Davis. (2016). Novel Methods of Insulin Replacement: The Artificial Pancreas and Encapsulated Islets. Reviews on Recent Clinical Trials. 11(2). 106–123. 6 indexed citations

Lamos, Elizabeth M., Lisa M. Younk, Donna B. Tate, & Stephen N. Davis. (2015). Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals. Journal of Clinical & Translational Endocrinology. 3. 14–20. 4 indexed citations

Kirk, Julienne K., et al.. (2014). Perceptions of culturally competent diabetes management in a primary care practice.. PubMed. 21(1). 22–8. 4 indexed citations

Younk, Lisa M., Elizabeth M. Lamos, & Stephen N. Davis. (2014). The cardiovascular effects of insulin. Expert Opinion on Drug Safety. 13(7). 955–966. 17 indexed citations

Hedrington, Maka S. & Stephen N. Davis. (2014). Discontinued in 2013: diabetic drugs. Expert Opinion on Investigational Drugs. 23(12). 1703–1711. 24 indexed citations

10.

Кониг, Маниге, et al.. (2013). An Insight into the Recent Diabetes Trials: What is the Best Approach to Prevent Macrovascular and Microvascular Complications?. Current Diabetes Reviews. 9(5). 371–381. 35 indexed citations

11.

Lamos, Elizabeth M., Lisa M. Younk, & Stephen N. Davis. (2013). Canagliflozin, an inhibitor of sodium–glucose cotransporter 2, for the treatment of type 2 diabetes mellitus. Expert Opinion on Drug Metabolism & Toxicology. 9(6). 763–775. 45 indexed citations

12.

Buse, John B., Yogish C. Kudva, Tadej Battelino, et al.. (2012). Effects of Sensor-Augmented Pump Therapy on Glycemic Variability in Well-Controlled Type 1 Diabetes in the STAR 3 Study. Diabetes Technology & Therapeutics. 14(7). 644–647. 29 indexed citations

13.

Briscoe, Vanessa Jones, Michelle L. Griffith, & Stephen N. Davis. (2010). The role of glimepiride in the treatment of type 2 diabetes mellitus. Expert Opinion on Drug Metabolism & Toxicology. 6(2). 225–235. 34 indexed citations

14.

Davis, Stephen N. & Jennifer M. Perkins. (2007). Role of the Endocannabinoid System in Management of Patients with Type 2 Diabetes Mellitus and Cardiovascular Risk Factors. Endocrine Practice. 13(7). 790–804. 4 indexed citations

15.

Davis, Stephen N. & Julia P. Dunn. (2006). Hypoglycemia—The Major Barrier to Good Glycemic Control. US Endocrinology. 0(1). 2–2. 1 indexed citations

16.

Moore, Mary Courtney, et al.. (2000). Acute Fructose Administration Decreases the Glycemic Response to an Oral Glucose Tolerance Test in Normal Adults¹. The Journal of Clinical Endocrinology & Metabolism. 85(12). 4515–4519. 105 indexed citations

17.

Dobbins, Robert L., Stephen N. Davis, Doss W. Neal, et al.. (1998). Rates of glucagon activation and deactivation of hepatic glucose production in conscious dogs. Metabolism. 47(2). 135–142. 11 indexed citations

18.

Davis, Stephen N., Robert L. Dobbins, Stephen E. Nadeau, et al.. (1995). Evidence that the brain of the conscious dog is insulin sensitive.. Journal of Clinical Investigation. 95(2). 593–602. 53 indexed citations

19.

Davis, Stephen N., PierMarco Piatti, C. Hetherington, et al.. (1993). The effects of subcutaneous human proinsulin on the production of split proinsulin, glucose turnover and intermediary metabolism in non-insulin-dependent diabetic man. Diabetes Research and Clinical Practice. 19(2). 103–113. 3 indexed citations

20.

Davis, Stephen N., et al.. (1960). Congenital tuberculosis. The Journal of Pediatrics. 57(2). 221–224. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact